Reply to Finsterer and Mehri "Assessing post-COVID myopathy by MRI requires large cohorts and comparison with a gold standard"

Eur J Neurol. 2023 Jun;30(6):1839-1840. doi: 10.1111/ene.15774. Epub 2023 Mar 26.

Authors

Elena Enax-Krumova¹, Johannes Forsting¹, Marlena Rohm^{1

2}, Peter Schwenkreis¹, Martin Tegenthoff¹, Christine H Meyer-Frießem³, Lara Schlaffke^{1

2}

Affiliations

¹ Department of Neurology, BG-University Hospital Bergmannsheil gGmbH, Ruhr-University Bochum, Bochum, Germany.
² Heimer Institute for Muscle Research, BG-University Hospital Bergmannsheil gGmbH, Bochum, Germany.
³ Department of Anaesthesiology, Intensive Care and Pain Management, BG-University Hospital Bergmannsheil gGmbH, Ruhr-University Bochum, Bochum, Germany.

PMID: 36916666
DOI: 10.1111/ene.15774

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Humans
Magnetic Resonance Imaging
Muscular Diseases* / diagnostic imaging
Mutation